Chescapmanager’s Bristol-Myers Squibb BMY Stock Holding History

Chescapmanager’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250,000	Closed	-$15.8M	–	73
2021 Q1	$15.8M	Sell	250,000 -474,500	-65%	-$29.5M	1.68%	27
2020 Q4	$44.9M	Buy	+724,500	New	+$44.5M	5.48%	3
2020 Q3	–	Sell	-100,000	Closed	-$5.88M	–	56
2020 Q2	$5.88M	Buy	+100,000	New	+$5.98M	0.99%	25
2019 Q2	–	Sell	-250,000	Closed	-$11.9M	–	41
2019 Q1	$11.9M	Buy	+250,000	New	+$12.5M	1.42%	21

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Chescapmanager's BMY Position: Q4 2022 in Review

Chescapmanager sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 90,852 shares — an estimated $6.46M sold.

Chescapmanager first reported a position in BMY in Q1 2017 and held it in 21 quarters. The position peaked at $29.8M in Q2 2021. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Chescapmanager reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Chescapmanager sold 90,852 Bristol-Myers Squibb shares in Q4 2022, an estimated $6.46M.
Chescapmanager first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 21 quarters.
Chescapmanager's Bristol-Myers Squibb position peaked at $29.8M in Q2 2021.
2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Chescapmanager's 13F filing for Q4 2022, filed 14 Feb 2023.